Does ADALIMUMAB Cause Bladder cancer? 268 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 268 reports of Bladder cancer have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.1% of all adverse event reports for ADALIMUMAB.
268
Reports of Bladder cancer with ADALIMUMAB
0.1%
of all ADALIMUMAB reports
24
Deaths
78
Hospitalizations
How Dangerous Is Bladder cancer From ADALIMUMAB?
Of the 268 reports, 24 (9.0%) resulted in death, 78 (29.1%) required hospitalization, and 10 (3.7%) were considered life-threatening.
Is Bladder cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 268 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Bladder cancer?
RANITIDINE (41,984)
PIOGLITAZONE (7,295)
METFORMIN\PIOGLITAZONE (278)
ETANERCEPT (225)
METHOTREXATE (179)
INFLIXIMAB (165)
APIXABAN (159)
VALSARTAN (144)
LENALIDOMIDE (120)
LEUPROLIDE (99)
Which ADALIMUMAB Alternatives Have Lower Bladder cancer Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB